Associations between metabolites and pancreatic cancer risk in a large prospective epidemiological study
- 14 February 2020
- Vol. 69 (11), 2008-2015
- https://doi.org/10.1136/gutjnl-2019-319811
Abstract
Objective To assess whether prediagnostic metabolites were associated with incident pancreatic ductal adenocarcinoma (PDAC) in a prospective cohort study. Design We conducted an untargeted analysis of 554 known metabolites measured in prediagnostic serum (up to 24 years) to determine their association with incident PDAC in a nested case-control study of male smokers (372 matched case-control sets) and an independent nested case-control study that included women and non-smokers (107 matched sets). Metabolites were measured using Orbitrap Elite or Q-Exactive high-resolution/accurate mass spectrometers. Controls were matched to cases by age, sex, race, date of blood draw, and follow-up time. We used conditional logistic regression adjusted for age to calculate ORs and 95% CIs for a 1 SD increase in log-metabolite level separately in each cohort and combined the two ORs using a fixed-effects meta-analysis. Results Thirty-one metabolites were significantly associated with PDAC at a false discovery rate –5). Similar associations were observed in both cohorts. The dipeptides glycylvaline, aspartylphenylalanine, pyroglutamylglycine, phenylalanylphenylalanine, phenylalanylleucine and tryptophylglutamate and amino acids aspartate and glutamate were positively while the dipeptides tyrosylglutamine and α-glutamyltyrosine, fibrinogen cleavage peptide DSGEGDFXAEGGGVR and glutathione-related amino acid cysteine-glutathione disulfide were inversely associated with PDAC after Bonferroni correction. Five top metabolites demonstrated significant time-varying associations (pConclusion Our results suggest that prediagnostic metabolites related to subclinical disease, γ-glutamyl cycle metabolism and adiposity/insulin resistance are associated with PDAC.Keywords
Funding Information
- Intramural Research Program of the National Cancer Institute, National Institutes of Health, Department of Health and Human Services
- Department of Defense, Peer Review Cancer Research Program Discovery Award (W81XWH-12-1-0369)
This publication has 48 references indexed in Scilit:
- Purine Metabolites and Carnitine Biosynthesis Intermediates Are Biomarkers for Incident Type 2 DiabetesJournal of Clinical Endocrinology & Metabolism, 2019
- A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal WomenCancer Prevention Research, 2019
- Global Patterns and Trends in Pancreatic Cancer IncidencePancreas, 2019
- Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumorsNature Medicine, 2016
- Metabolite Signatures of Metabolic Risk Factors and their Longitudinal ChangesJournal of Clinical Endocrinology & Metabolism, 2016
- Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma developmentNature Medicine, 2014
- Gamma-Glutamyltransferase and Cancer Incidence: The Ohsaki Cohort StudyJournal of Epidemiology, 2012
- A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer riskInternational Journal of Cancer, 2010
- Integrated, Nontargeted Ultrahigh Performance Liquid Chromatography/Electrospray Ionization Tandem Mass Spectrometry Platform for the Identification and Relative Quantification of the Small-Molecule Complement of Biological SystemsAnalytical Chemistry, 2009
- Prospective study of urinary excretion of 7‐methylguanine and the risk of lung cancer: Effect modification by mu class glutathione‐S‐transferasesInternational Journal of Cancer, 2007